Goldman Sachs
IMA

Goldman Sachs’s ImageneBio Inc IMA Stock Holding History

Goldman Sachs’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.4K Buy
15,485
+4,027
+35% +$22.7K ﹤0.01% 6346
2026
Q1 		$57.3K Buy
11,458
+508
+5% +$3.3K ﹤0.01% 6286
2025
Q4 		$75.6K Buy
+10,950
New +$81.2K ﹤0.01% 6238
2025
Q3 		– Sell
-5,555
Closed -$89.3K – 6488
2025
Q2 		$89.3K Sell
5,555
-817
-13% -$12K ﹤0.01% 5839
2025
Q1 		$97.9K Buy
6,372
+2,447
+62% +$42.2K ﹤0.01% 5789
2024
Q4 		$77.2K Sell
3,925
-960
-20% -$19.4K ﹤0.01% 5804
2024
Q3 		$101K Sell
4,885
-17,935
-79% -$363K ﹤0.01% 5568
2024
Q2 		$452K Buy
22,820
+16,770
+277% +$296K ﹤0.01% 4888
2024
Q1 		$103K Buy
6,050
+4,084
+208% +$74.4K ﹤0.01% 5244
2023
Q4 		$46.5K Buy
1,966
+184
+10% +$6K ﹤0.01% 5383
2023
Q3 		$92.6K Buy
1,782
+303
+20% +$18.2K ﹤0.01% 5195
2023
Q2 		$116K Sell
1,479
-1,454
-50% -$104K ﹤0.01% 5332
2023
Q1 		$121K Buy
+2,933
New +$135K ﹤0.01% 5423
2022
Q4 		– Sell
-1,036
Closed -$44K – 6125
2022
Q3 		$44K Sell
1,036
-928
-47% -$53.7K ﹤0.01% 5818
2022
Q2 		$105K Sell
1,964
-213
-10% -$11.8K ﹤0.01% 5845
2022
Q1 		$160K Buy
2,177
+1,105
+103% +$117K ﹤0.01% 5954
2021
Q4 		$161K Buy
+1,072
New +$174K ﹤0.01% 5982
2021
Q2 		– Sell
-3,258
Closed -$1.1M – 6354
2021
Q1 		$1.1M Buy
+3,258
New +$1.12M ﹤0.01% 4528

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Goldman Sachs's IMA Position: Q2 2026 in Review

Goldman Sachs increased its ImageneBio Inc (IMA) stake by 35% in Q2 2026, buying an estimated $22.7K and bringing the position to 15,485 shares worth $91.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6346.

Goldman Sachs first reported a position in IMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.1M in Q1 2021. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Goldman Sachs held 15,485 shares of ImageneBio Inc worth $91.4K as of Q2 2026.
  • Goldman Sachs bought 4,027 ImageneBio Inc shares in Q2 2026, an estimated $22.7K.
  • ImageneBio Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6346 holding.
  • Goldman Sachs first reported a position in ImageneBio Inc in Q1 2021 and has held it in 18 quarters since.
  • Goldman Sachs's ImageneBio Inc position peaked at $1.1M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.